OKLAHOMA CITY, December 17, 2004 – The Oklahoma Medical Research Foundation has named Rodger McEver, M.D., as Vice President of Research and Tim Hassen as Chief Financial Officer.
|Dr. Rodger McEver||McEver holds a B.A. from Yale University and earned his medical degree at the University of Chicago. He joined OMRF’s scientific staff in 1987 and currently holds the Eli Lilly Chair in Biomedical Research. Previously, McEver was a George Lynn Cross Research Professor at the University of Oklahoma Health Sciences Center, where he remains an adjunct professor of biochemistry and molecular biology.
In 2004, McEver secured more than $4 million in National Institutes of Health grants, making him one of the most highly funded researchers in Oklahoma. “Rod McEver is a tremendous scientist, and I have no doubt he will provide both a steady hand and tremendous vision as he guides our researchers into a new period of growth and discovery,” said OMRF President J. Donald Capra, M.D.
OMRF also named Hassen as CFO. Since 2000, Hassen has served as OMRF’s controller. A registered C.P.A., he holds a B.S. in accounting from the University of Central Oklahoma and an M.B.A. from Oklahoma City University. Prior to joining OMRF, he worked for the accounting firm Deloitte & Touche.“As controller, Tim Hassen has been a model steward for the funds that have been entrusted to OMRF,” said Mike D. “Chip” Morgan, OMRF’s Vice President for Business Operations. “His thorough understanding of finance and his deep loyalty to OMRF make him an ideal choice for CFO.”
Chartered in 1946, OMRF (www.omrf.org) is a nonprofit biomedical research institute dedicated to understanding and curing human disease. Its scientists focus on such critical research areas as Alzheimer’s disease, cancer, lupus and cardiovascular disease. OMRF is home to Oklahoma’s only member of the National Academy of Sciences.